Literature DB >> 10523522

A multilocus genotyping assay for candidate markers of cardiovascular disease risk.

S Cheng1, M A Grow, C Pallaud, W Klitz, H A Erlich, S Visvikis, J J Chen, C R Pullinger, M J Malloy, G Siest, J P Kane.   

Abstract

A number of chronic diseases, including cardiovascular disease, appear to have a multifactorial genetic risk component. Consequently, techniques are needed to facilitate evaluation of complex genetic risk factors in large cohorts. We have designed a prototype assay for genotyping a panel of 35 biallelic sites that represent variation within 15 genes from biochemical pathways implicated in the development and progression of cardiovascular disease. Each DNA sample is amplified using two multiplex polymerase chain reactions, and the alleles are genotyped simultaneously using an array of immobilized, sequence-specific oligonucleotide probes. This multilocus assay was applied to two types of cohorts. Population frequencies for the markers were estimated using 496 unrelated individuals from a family-based cohort, and the observed values were consistent with previous reports. Linkage disequilibrium between consecutive pairs of markers within the apoCIII, LPL, and ELAM genes was also estimated. A preliminary analysis of single and pairwise locus associations with severity of atherosclerosis was performed using a composite cohort of 142 individuals for whom quantitative angiography data were available; evaluation of the potentially interesting associations observed will require analysis of an independent and larger cohort. This assay format provides a research tool for studies of multilocus genetic risk factors in large cardiovascular disease cohorts, and for the subsequent development of diagnostic tests.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523522      PMCID: PMC310821          DOI: 10.1101/gr.9.10.936

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  101 in total

1.  Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease.

Authors:  J M Ordovas; F Civeira; J Genest; S Craig; A H Robbins; T Meade; M Pocovi; P M Frossard; U Masharani; P W Wilson
Journal:  Atherosclerosis       Date:  1991-03       Impact factor: 5.162

2.  A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity.

Authors:  W S Yang; D N Nevin; R Peng; J D Brunzell; S S Deeb
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

3.  Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis.

Authors:  E Ludwig; P S Corneli; J L Anderson; H W Marshall; J M Lalouel; R H Ward
Journal:  Circulation       Date:  1995-04-15       Impact factor: 29.690

4.  Molecular basis of cystathionine beta-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria.

Authors:  F L Hu; Z Gu; V Kozich; J P Kraus; V Ramesh; V E Shih
Journal:  Hum Mol Genet       Date:  1993-11       Impact factor: 6.150

5.  A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease.

Authors:  K Lindpaintner; M A Pfeffer; R Kreutz; M J Stampfer; F Grodstein; F LaMotte; J Buring; C H Hennekens
Journal:  N Engl J Med       Date:  1995-03-16       Impact factor: 91.245

6.  Characterization of a cystathionine beta-synthase allele with three mutations in cis in a patient with B6 nonresponsive homocystinuria.

Authors:  M Marble; M T Geraghty; R de Franchis; J P Kraus; D Valle
Journal:  Hum Mol Genet       Date:  1994-10       Impact factor: 6.150

7.  Apolipoprotein B polymorphism and altered apolipoprotein B and low density lipoprotein cholesterol concentrations in Finnish children.

Authors:  M J Tikkanen; J Viikari; H K Akerblom; E Pesonen
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-16

Review 8.  27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 3. Spectrum of risk factors for coronary heart disease.

Authors:  R C Pasternak; S M Grundy; D Levy; P D Thompson
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094

9.  PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1).

Authors:  B Rigat; C Hubert; P Corvol; F Soubrier
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

10.  A common variant in the gene for lipoprotein lipase (Asp9-->Asn). Functional implications and prevalence in normal and hyperlipidemic subjects.

Authors:  F Mailly; Y Tugrul; P W Reymer; T Bruin; M Seed; B F Groenemeyer; A Asplund-Carlson; D Vallance; A F Winder; G J Miller
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-04       Impact factor: 8.311

View more
  57 in total

Review 1.  Angiotensin I-converting enzyme: genotype and disease associations.

Authors:  D Crisan; J Carr
Journal:  J Mol Diagn       Date:  2000-08       Impact factor: 5.568

2.  Recurrent miscarriage and variant alleles of mannose binding lectin, tumour necrosis factor and lymphotoxin alpha genes.

Authors:  N Baxter; M Sumiya; S Cheng; H Erlich; L Regan; A Simons; J A Summerfield
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

3.  A method for the assessment of disease associations with single-nucleotide polymorphism haplotypes and environmental variables in case-control studies.

Authors:  Lue Ping Zhao; Shuying Sue Li; Najma Khalid
Journal:  Am J Hum Genet       Date:  2003-04-16       Impact factor: 11.025

4.  Search for haplotype interactions that influence susceptibility to type 1 diabetes, through use of unphased genotype data.

Authors:  Jian Zhang; Faming Liang; Willem R M Dassen; Bart A J Veldman; Pieter A Doevendans; Mathisca De Gunst
Journal:  Am J Hum Genet       Date:  2003-11-21       Impact factor: 11.025

5.  Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study.

Authors:  Amy I Lynch; John H Eckfeldt; Barry R Davis; Charles E Ford; Eric Boerwinkle; Catherine Leiendecker-Foster; Donna K Arnett
Journal:  Pharmacogenet Genomics       Date:  2012-05       Impact factor: 2.089

6.  Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment study.

Authors:  Richard Sherva; Charles E Ford; John H Eckfeldt; Barry R Davis; Eric Boerwinkle; Donna K Arnett
Journal:  Stroke       Date:  2010-12-23       Impact factor: 7.914

7.  The glu298asp polymorphism in the nitric oxide synthase 3 gene is associated with the risk of ischemic stroke in two large independent case-control studies.

Authors:  Klaus Berger; Florian Stögbauer; Monika Stoll; Juergen Wellmann; Andreas Huge; Suzanne Cheng; Christof Kessler; Ulrich John; Gerd Assmann; E Bernd Ringelstein; Harald Funke
Journal:  Hum Genet       Date:  2006-12-13       Impact factor: 4.132

8.  Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q.

Authors:  Carole Ober; Alex S Nord; Emma E Thompson; Lin Pan; Zheng Tan; Darren Cusanovich; Ying Sun; Raluca Nicolae; Celina Edelstein; Daniel H Schneider; Christine Billstrand; Ditta Pfaffinger; Natasha Phillips; Rebecca L Anderson; Binu Philips; Ramakrishnan Rajagopalan; Thomas S Hatsukami; Mark J Rieder; Patrick J Heagerty; Deborah A Nickerson; Mark Abney; Santica Marcovina; Gail P Jarvik; Angelo M Scanu; Dan L Nicolae
Journal:  J Lipid Res       Date:  2009-01-05       Impact factor: 5.922

9.  Linkage disequilibrium with predisposing DR3 haplotypes accounts for apparent effects of tumor necrosis factor and lymphotoxin-alpha polymorphisms on type 1 diabetes susceptibility.

Authors:  Janelle A Noble; Ana M Valdes; Julie A Lane; Amy E Green; Henry A Erlich
Journal:  Hum Immunol       Date:  2006-10-30       Impact factor: 2.850

10.  Polymorphisms in the renin-angiotensin system and migraine in women.

Authors:  Markus Schürks; Robert Y L Zee; Julie E Buring; Tobias Kurth
Journal:  Headache       Date:  2008-10-27       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.